Science Immunology · 2024 · 22 citations · 81 references
Life SciencesImmunologyMolecular BiologyApoptosisCell SignalingSignal TransductionCell-mediated ImmunityImmune Checkpoint RegulationImmune CheckpointsImmune RegulationT Cell ActivationT Cell ExhaustionChronic Antigen StimulationImmune Checkpoint Signaling PathwaysNrf2 Signaling PathwayPersistent Antigen ExposureRedox Sensing MechanismsRegulation Of T-cell ActivationStem-like Exhausted T CellsT-cell Exhaustion Regulation
During persistent antigen stimulation, exhausted CD8 + T cells are continuously replenished by self-renewing stem-like T cells. However, how CD8 + T cells adapt to chronic stimulation remains unclear. Here, we show that persistent antigen stimulation primes chromatin for regulation by the redox-sensing KEAP1-NRF2 pathway. Loss of KEAP1 in T cells impaired control of chronic viral infection. T cell–intrinsic KEAP1 suppressed NRF2 to promote expansion and persistence of virus-specific CD8 + T cells, drive a stem-like T cell response, down-regulate immune checkpoint molecules, and limit T cell receptor (TCR) hyperactivation and apoptosis. NRF2 epigenetically derepressed BACH2 targets and opposed a stem-like program driven by BACH2. In exhausted T cells induced by tonic GD2 chimeric antigen receptor (CAR) signaling, the effects of KEAP1 deficiency were rescued by inhibiting proximal TCR signaling. Enhancing mitochondrial oxidation improved the expansion and survival of KEAP1-deficient CD8 + GD2 CAR T cells and up-regulated markers associated with stem-like cells. Thus, the KEAP1-NRF2 axis regulates stem-like CD8 + T cells and long-term T cell immunity during chronic antigen exposure.
81
Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
Se Jin Im, Masao Hashimoto, Michael Y. Gerner et al. · Nature · 2016 · 2.1K citations · Full text
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Moshe Sade-Feldman, Keren Yizhak, Stacey L. Bjorgaard et al. · Cell · 2018 · 2K citations · Full text
Life Sciences, Immunology, Oncology +14